{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:23:36Z","timestamp":1788384216573,"version":"build-2803163510"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL044491-21"],"award-info":[{"award-number":["R01 HL044491-21"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008955","name":"Maine Medical Center Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.cellsig.2020.109554","type":"journal-article","created":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T12:05:15Z","timestamp":1580731515000},"page":"109554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR\/JAK2 Signaling"],"prefix":"10.1016","volume":"69","author":[{"given":"Matthew A.","family":"Held","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Greenfest-Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian J.","family":"Stoeckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Stokes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don M.","family":"Wojchowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"47","key":"10.1016\/j.cellsig.2020.109554_bb0005","doi-asserted-by":"crossref","first-page":"6715","DOI":"10.1038\/sj.onc.1210756","article-title":"Cytokine receptors and hematopoietic differentiation","volume":"26","author":"Robb","year":"2007","journal-title":"Oncogene."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109554_bb0010","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S1097-2765(01)00401-4","article-title":"The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor","volume":"8","author":"Huang","year":"2001","journal-title":"Mol. Cell"},{"issue":"34","key":"10.1016\/j.cellsig.2020.109554_bb0015","doi-asserted-by":"crossref","first-page":"35486","DOI":"10.1074\/jbc.M404202200","article-title":"Janus kinase (Jak) subcellular localization revisited: the exclusive membrane localization of endogenous Janus kinase 1 by cytokine receptor interaction uncovers the Jak.Receptor complex to be equivalent to a receptor tyrosine kinase","volume":"279","author":"Behrmann","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2020.109554_bb0020","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.38089","article-title":"Receptor-mediated dimerization of JAK2 FERM domains is required for JAK2 activation","volume":"7","author":"Ferrao","year":"2018","journal-title":"Elife."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109554_bb0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0092-8674(95)90234-1","article-title":"Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor","volume":"83","author":"Wu","year":"1995","journal-title":"Cell."},{"issue":"7","key":"10.1016\/j.cellsig.2020.109554_bb0030","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1182\/blood-2002-01-0124","article-title":"Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality","volume":"100","author":"Suzuki","year":"2002","journal-title":"Blood."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109554_bb0035","doi-asserted-by":"crossref","first-page":"209","DOI":"10.23876\/j.krcp.2017.36.3.209","article-title":"Treatment of renal anemia: erythropoiesis stimulating agents and beyond","volume":"36","author":"Biggar","year":"2017","journal-title":"Kidney Res Clin Pract."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109554_bb0040","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/leu.2015.296","article-title":"Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion","volume":"30","author":"Toma","year":"2016","journal-title":"Leukemia."},{"key":"10.1016\/j.cellsig.2020.109554_bb0045","doi-asserted-by":"crossref","unstructured":"Aapro M, Beguin Y, Bokemeyer C, et al. Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines. Ann Oncol. 2018;29(Suppl 4):iv271.","DOI":"10.1093\/annonc\/mdy323"},{"issue":"4","key":"10.1016\/j.cellsig.2020.109554_bb0050","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.clinthera.2014.02.007","article-title":"Dose efficiency of erythropoiesis-stimulating agents for the treatment of patients with chemotherapy-induced anemia: a systematic review","volume":"36","author":"Forbes","year":"2014","journal-title":"Clin. Ther."},{"issue":"10","key":"10.1016\/j.cellsig.2020.109554_bb0055","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1093\/ndt\/gfx324","article-title":"Mechanisms and mediators of hypertension induced by erythropoietin and related molecules","volume":"33","author":"Agarwal","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"issue":"395","key":"10.1016\/j.cellsig.2020.109554_bb0060","doi-asserted-by":"crossref","first-page":"pe38","DOI":"10.1126\/stke.3952007pe38","article-title":"Does erythropoietin have a dark side? Epo signaling and cancer cells","volume":"2007","author":"Sytkowski","year":"2007","journal-title":"Sci. STKE"},{"issue":"7","key":"10.1016\/j.cellsig.2020.109554_bb0065","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/ng.2996","article-title":"Identification of erythroferrone as an erythroid regulator of iron metabolism","volume":"46","author":"Kautz","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cellsig.2020.109554_bb0070","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3389\/fphys.2019.00304","article-title":"The EPO-FGF23 Signaling pathway in Erythroid progenitor cells: opening a new area of research","volume":"10","author":"van Vuren","year":"2019","journal-title":"Front. Physiol."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109554_bb0075","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1084\/jem.20121762","article-title":"Erythropoietin-directed erythropoiesis depends on serpin inhibition of erythroblast lysosomal cathepsins","volume":"210","author":"Dev","year":"2013","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109554_bb0080","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/17474086.2018.1450628","article-title":"Beyond JAK-2: potential targets for myeloproliferative neoplasm therapy","volume":"11","author":"Harrington","year":"2018","journal-title":"Expert. Rev. Hematol."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109554_bb0085","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00277-018-3526-z","article-title":"Treating early-stage myelofibrosis","volume":"98","author":"Palandri","year":"2019","journal-title":"Ann. Hematol."},{"issue":"7","key":"10.1016\/j.cellsig.2020.109554_bb0090","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s40265-018-0908-4","article-title":"Baricitinib: a review in rheumatoid arthritis","volume":"78","author":"Al-Salama","year":"2018","journal-title":"Drugs."},{"key":"10.1016\/j.cellsig.2020.109554_bb0095","doi-asserted-by":"crossref","unstructured":"Guttman-Yassky E, Silverberg JI, Nemoto O, et al. Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study. J Am Acad Dermatol. 2019;80(4):913\u2013921 e919.","DOI":"10.1016\/j.jaad.2018.01.018"},{"issue":"1","key":"10.1016\/j.cellsig.2020.109554_bb0100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/2040620712461047","article-title":"Comprehensive review of JAK inhibitors in myeloproliferative neoplasms","volume":"4","author":"Sonbol","year":"2013","journal-title":"Ther Adv Hematol."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109554_bb0105","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/S2352-3026(17)30237-5","article-title":"Momelotinib versus best available therapy in patients with myelofibrosis previously treated with ruxolitinib (SIMPLIFY 2): a randomised, open-label, phase 3 trial","volume":"5","author":"Harrison","year":"2018","journal-title":"Lancet Haematol."},{"issue":"26","key":"10.1016\/j.cellsig.2020.109554_bb0110","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1182\/blood-2014-05-576652","article-title":"Cooperating JAK1 and JAK3 mutants increase resistance to JAK inhibitors","volume":"124","author":"Springuel","year":"2014","journal-title":"Blood."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109554_bb0115","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1517\/14728222.2016.1090975","article-title":"Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis","volume":"20","author":"Rainville","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.cellsig.2020.109554_bb0120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-4939-2095-2_3","article-title":"Erythropoiesis: from molecular pathways to system properties","volume":"844","author":"Koulnis","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.cellsig.2020.109554_bb0125","doi-asserted-by":"crossref","unstructured":"Kim AR, Ulirsch JC, Wilmes S, et al. Functional Selectivity in Cytokine Signaling Revealed Through a Pathogenic EPO Mutation. Cell. 2017;168(6):1053\u20131064 e1015.","DOI":"10.1016\/j.cell.2017.02.026"},{"issue":"1","key":"10.1016\/j.cellsig.2020.109554_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20140712","article-title":"The molecular regulation of Janus kinase (JAK) activation","volume":"462","author":"Babon","year":"2014","journal-title":"Biochem. J."},{"issue":"52","key":"10.1016\/j.cellsig.2020.109554_bb0135","doi-asserted-by":"crossref","first-page":"18962","DOI":"10.1073\/pnas.0509714102","article-title":"Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation","volume":"102","author":"Lu","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7265","key":"10.1016\/j.cellsig.2020.109554_bb0140","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nature08448","article-title":"JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin","volume":"461","author":"Dawson","year":"2009","journal-title":"Nature."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109554_bb0145","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1158\/2159-8290.CD-18-1138","article-title":"Cytokine-regulated phosphorylation and activation of TET2 by JAK2 in Hematopoiesis","volume":"9","author":"Jeong","year":"2019","journal-title":"Cancer Discov."},{"issue":"10","key":"10.1016\/j.cellsig.2020.109554_bb0150","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1182\/blood.V91.10.3734","article-title":"Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway","volume":"91","author":"Chin","year":"1998","journal-title":"Blood."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109554_bb0155","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/ajh.25295","article-title":"Fyn kinase is a novel modulator of erythropoietin signaling and stress erythropoiesis","volume":"94","author":"Beneduce","year":"2019","journal-title":"Am. J. Hematol."},{"issue":"5","key":"10.1016\/j.cellsig.2020.109554_bb0160","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1182\/blood.V91.5.1496","article-title":"Tec and Jak2 kinases cooperate to mediate cytokine-driven activation of c-fos transcription","volume":"91","author":"Yamashita","year":"1998","journal-title":"Blood."},{"issue":"12","key":"10.1016\/j.cellsig.2020.109554_bb0165","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1182\/blood-2004-10-4093","article-title":"Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways","volume":"105","author":"Tong","year":"2005","journal-title":"Blood."},{"issue":"9","key":"10.1016\/j.cellsig.2020.109554_bb0170","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1182\/blood.V89.9.3148","article-title":"CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation","volume":"89","author":"Matsumoto","year":"1997","journal-title":"Blood."},{"issue":"11","key":"10.1016\/j.cellsig.2020.109554_bb0175","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1182\/blood-2006-08-039735","article-title":"The myeloproliferative disorder-associated JAK2 V617F mutant escapes negative regulation by suppressor of cytokine signaling 3","volume":"109","author":"Hookham","year":"2007","journal-title":"Blood."},{"issue":"24","key":"10.1016\/j.cellsig.2020.109554_bb0180","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1182\/blood-2013-05-506212","article-title":"Cbl ubiquitination of p85 is essential for Epo-induced EpoR endocytosis","volume":"122","author":"Bulut","year":"2013","journal-title":"Blood."},{"issue":"12","key":"10.1016\/j.cellsig.2020.109554_bb0185","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1182\/blood-2006-10-055350","article-title":"Beta-Trcp mediates ubiquitination and degradation of the erythropoietin receptor and controls cell proliferation","volume":"109","author":"Meyer","year":"2007","journal-title":"Blood."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109554_bb0190","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1074\/jbc.275.6.4398","article-title":"The SH2 inositol 5-phosphatase Ship1 is recruited in an SH2-dependent manner to the erythropoietin receptor","volume":"275","author":"Mason","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.cellsig.2020.109554_bb0195","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.2337\/diabetes.51.7.2012","article-title":"The gene INPPL1, encoding the lipid phosphatase SHIP2, is a candidate for type 2 diabetes in rat and man","volume":"51","author":"Marion","year":"2002","journal-title":"Diabetes."},{"issue":"10","key":"10.1016\/j.cellsig.2020.109554_bb0200","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1182\/blood.V91.10.3746","article-title":"SHP-1 phosphatase C-terminus interacts with novel substrates p32\/p30 during erythropoietin and interleukin-3 mitogenic responses","volume":"91","author":"Yang","year":"1998","journal-title":"Blood."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109554_bb0205","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1006\/bbrc.1997.7480","article-title":"Erythropoietin and IL-3 induce tyrosine phosphorylation of CrkL and its association with Shc, SHP-2, and Cbl in hematopoietic cells","volume":"239","author":"Chin","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellsig.2020.109554_bb0210","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3389\/fimmu.2018.00931","article-title":"Regulation of hematopoietic cell development and function through Phosphoinositides","volume":"9","author":"Elich","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2020.109554_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(03)00400-1","article-title":"The function of the protein tyrosine phosphatase SHP-1 in cancer","volume":"306","author":"Wu","year":"2003","journal-title":"Gene."},{"issue":"5","key":"10.1016\/j.cellsig.2020.109554_bb0220","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1084\/jem.20171477","article-title":"SHP-1 regulates hematopoietic stem cell quiescence by coordinating TGF-beta signaling","volume":"215","author":"Jiang","year":"2018","journal-title":"J. Exp. Med."},{"issue":"43","key":"10.1016\/j.cellsig.2020.109554_bb0225","doi-asserted-by":"crossref","first-page":"13342","DOI":"10.1073\/pnas.1507599112","article-title":"Shp2 and Pten have antagonistic roles in myeloproliferation but cooperate to promote erythropoiesis in mammals","volume":"112","author":"Zhu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109554_bb0230","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng1156","article-title":"Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia","volume":"34","author":"Tartaglia","year":"2003","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109554_bb0235","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1182\/blood.V82.2.456.456","article-title":"Establishment and characterization of an erythropoietin-dependent subline, UT-7\/Epo, derived from human leukemia cell line, UT-7","volume":"82","author":"Komatsu","year":"1993","journal-title":"Blood."},{"issue":"15","key":"10.1016\/j.cellsig.2020.109554_bb0240","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.1073\/pnas.88.15.6595","article-title":"Molecular identification of a major palmitoylated erythrocyte membrane protein containing the src homology 3 motif","volume":"88","author":"Ruff","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.cellsig.2020.109554_bb0245","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.bbamem.2017.08.021","article-title":"MPP1 directly interacts with flotillins in erythrocyte membrane - possible mechanism of raft domain formation","volume":"1859","author":"Biernatowska","year":"2017","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109554_bb0250","doi-asserted-by":"crossref","first-page":"E29","DOI":"10.1002\/ajh.25323","article-title":"MPP1\/p55 gene deletion in a hemophilia a patient with ectrodactyly and severe developmental defects","volume":"94","author":"Fritz","year":"2019","journal-title":"Am. J. Hematol."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109554_bb0255","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.stem.2014.06.002","article-title":"Glucose and glutamine metabolism regulate human hematopoietic stem cell lineage specification","volume":"15","author":"Oburoglu","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"24","key":"10.1016\/j.cellsig.2020.109554_bb0260","doi-asserted-by":"crossref","first-page":"10920","DOI":"10.1073\/pnas.0914776107","article-title":"Pseudopodium-enriched atypical kinase 1 regulates the cytoskeleton and cancer progression [corrected]","volume":"107","author":"Wang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.cellsig.2020.109554_bb0265","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.chembiol.2011.03.017","article-title":"AAK1 identified as an inhibitor of neuregulin-1\/ErbB4-dependent neurotrophic factor signaling using integrative chemical genomics and proteomics","volume":"18","author":"Kuai","year":"2011","journal-title":"Chem. Biol."},{"key":"10.1016\/j.cellsig.2020.109554_bb0270","doi-asserted-by":"crossref","unstructured":"Agajanian MJ, Walker MP, Axtman AD, et al. WNT Activates the AAK1 Kinase to Promote Clathrin-Mediated Endocytosis of LRP6 and Establish a Negative Feedback Loop. Cell Rep. 2019;26(1):79\u201393 e78.","DOI":"10.1016\/j.celrep.2018.12.023"},{"issue":"2","key":"10.1016\/j.cellsig.2020.109554_bb0275","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.bbrc.2008.10.038","article-title":"MINK is a Rap2 effector for phosphorylation of the postsynaptic scaffold protein TANC1","volume":"377","author":"Nonaka","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"46","key":"10.1016\/j.cellsig.2020.109554_bb0280","doi-asserted-by":"crossref","first-page":"11074","DOI":"10.1523\/JNEUROSCI.0905-17.2017","article-title":"The Ste20 family kinases MAP4K4, MINK1, and TNIK converge to regulate stress-induced JNK Signaling in neurons","volume":"37","author":"Larhammar","year":"2017","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109554_bb0285","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1006\/bbrc.1995.2189","article-title":"Primary structure of BMK1: a new mammalian map kinase","volume":"213","author":"Lee","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109554_bb0290","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.18632\/oncotarget.23305","article-title":"Changes in metabolism affect expression of ABC transporters through ERK5 and depending on p53 status","volume":"9","author":"Belkahla","year":"2018","journal-title":"Oncotarget."},{"issue":"26","key":"10.1016\/j.cellsig.2020.109554_bb0295","doi-asserted-by":"crossref","first-page":"7904","DOI":"10.1021\/bi0340503","article-title":"The structure of the membrane distal phosphatase domain of RPTPalpha reveals interdomain flexibility and an SH2 domain interaction region","volume":"42","author":"Sonnenburg","year":"2003","journal-title":"Biochemistry."},{"issue":"11","key":"10.1016\/j.cellsig.2020.109554_bb0300","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nrm2039","article-title":"Protein tyrosine phosphatases: from genes, to function, to disease","volume":"7","author":"Tonks","year":"2006","journal-title":"Nat Rev Mol Cell Biol."},{"issue":"51","key":"10.1016\/j.cellsig.2020.109554_bb0305","doi-asserted-by":"crossref","first-page":"35815","DOI":"10.1074\/jbc.M807964200","article-title":"Activation of c-Src and Fyn kinases by protein-tyrosine phosphatase RPTPalpha is substrate-specific and compatible with lipid raft localization","volume":"283","author":"Vacaresse","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2020.109554_bb0310","doi-asserted-by":"crossref","DOI":"10.1038\/srep23658","article-title":"Structural and activity characterization of human PHPT1 after oxidative modification","volume":"6","author":"Martin","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109554_bb0315","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1073\/pnas.022518699","article-title":"Tensin1 and a previously undocumented family member, tensin2, positively regulate cell migration","volume":"99","author":"Chen","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109554_bb0320","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.molcel.2007.06.015","article-title":"A phosphatase activity of Sts-1 contributes to the suppression of TCR signaling","volume":"27","author":"Mikhailik","year":"2007","journal-title":"Mol. Cell"},{"issue":"9","key":"10.1016\/j.cellsig.2020.109554_bb0325","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/cr.2014.99","article-title":"The catalytic region and PEST domain of PTPN18 distinctly regulate the HER2 phosphorylation and ubiquitination barcodes","volume":"24","author":"Wang","year":"2014","journal-title":"Cell Res."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109554_bb0330","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1182\/blood.V88.4.1156.bloodjournal8841156","article-title":"A novel protein tyrosine phosphatase expressed in lin(lo)CD34(hi)Sca(hi) hematopoietic progenitor cells","volume":"88","author":"Cheng","year":"1996","journal-title":"Blood."},{"issue":"9","key":"10.1016\/j.cellsig.2020.109554_bb0335","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1084\/jem.20130624","article-title":"RHEX, a novel regulator of human erythroid progenitor cell expansion and erythroblast development","volume":"211","author":"Verma","year":"2014","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.cellsig.2020.109554_bb0340","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1073\/pnas.0609836104","article-title":"Large-scale phosphorylation analysis of mouse liver","volume":"104","author":"Villen","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.cellsig.2020.109554_bb0345","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.cell.2010.12.001","article-title":"A tissue-specific atlas of mouse protein phosphorylation and expression","volume":"143","author":"Huttlin","year":"2010","journal-title":"Cell."},{"issue":"11","key":"10.1016\/j.cellsig.2020.109554_bb0350","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/1044-0305(94)80016-2","article-title":"An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database","volume":"5","author":"Eng","year":"1994","journal-title":"J. Am. Soc. Mass Spectrom."},{"issue":"7","key":"10.1016\/j.cellsig.2020.109554_bb0355","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","article-title":"Skyline: an open source document editor for creating and analyzing targeted proteomics experiments","volume":"26","author":"MacLean","year":"2010","journal-title":"Bioinformatics."},{"issue":"D1","key":"10.1016\/j.cellsig.2020.109554_bb0360","doi-asserted-by":"crossref","first-page":"D362","DOI":"10.1093\/nar\/gkw937","article-title":"The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible","volume":"45","author":"Szklarczyk","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109554_bb0365","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1158\/2159-8290.CD-11-0324","article-title":"Modulation of activation-loop phosphorylation by JAK inhibitors is binding mode dependent","volume":"2","author":"Andraos","year":"2012","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109554_bb0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029064","article-title":"Dynamic ligand modulation of EPO receptor pools, and dysregulation by polycythemia-associated EPOR alleles","volume":"7","author":"Singh","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.cellsig.2020.109554_bb0375","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.exphem.2016.04.015","article-title":"A dimeric peptide with erythropoiesis-stimulating activity uniquely affects erythropoietin receptor ligation and cell surface expression","volume":"44","author":"Verma","year":"2016","journal-title":"Exp. Hematol."},{"issue":"23","key":"10.1016\/j.cellsig.2020.109554_bb0380","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1182\/blood-2014-11-575357","article-title":"Emerging EPO and EPO receptor regulators and signal transducers","volume":"125","author":"Kuhrt","year":"2015","journal-title":"Blood."},{"issue":"5","key":"10.1016\/j.cellsig.2020.109554_bb0385","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1128\/MCB.17.5.2497","article-title":"Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop","volume":"17","author":"Feng","year":"1997","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109554_bb0390","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1074\/jbc.M112.410910","article-title":"Dynamic phosphorylation of tyrosine 665 in pseudopodium-enriched atypical kinase 1 (PEAK1) is essential for the regulation of cell migration and focal adhesion turnover","volume":"288","author":"Bristow","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"7457","key":"10.1016\/j.cellsig.2020.109554_bb0395","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nature12308","article-title":"Temporal regulation of EGF signalling networks by the scaffold protein Shc1","volume":"499","author":"Zheng","year":"2013","journal-title":"Nature."},{"issue":"12","key":"10.1016\/j.cellsig.2020.109554_bb0400","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1046\/j.1398-9219.2003.0142.x","article-title":"AAK1-mediated micro2 phosphorylation is stimulated by assembled clathrin","volume":"4","author":"Conner","year":"2003","journal-title":"Traffic."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109554_bb0405","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/sj.cr.7290055","article-title":"The SHP-2 tyrosine phosphatase: signaling mechanisms and biological functions","volume":"10","author":"Qu","year":"2000","journal-title":"Cell Res."},{"issue":"12","key":"10.1016\/j.cellsig.2020.109554_bb0410","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1016\/j.bbamcr.2015.09.028","article-title":"Tensin1 positively regulates RhoA activity through its interaction with DLC1","volume":"1853","author":"Shih","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.cellsig.2020.109554_bb0415","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.4161\/cc.10.11.15776","article-title":"Tensin2 is a novel mediator in thrombopoietin (TPO)-induced cellular proliferation by promoting Akt signaling","volume":"10","author":"Jung","year":"2011","journal-title":"Cell Cycle"},{"issue":"4","key":"10.1016\/j.cellsig.2020.109554_bb0420","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.bbrc.2005.06.200","article-title":"The beta-subunit of G proteins is a substrate of protein histidine phosphatase","volume":"334","author":"Maurer","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.cellsig.2020.109554_bb0425","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1091\/mbc.e13-04-0180","article-title":"Regulation of the epithelial ca(2)(+) channel TRPV5 by reversible histidine phosphorylation mediated by NDPK-B and PHPT1","volume":"25","author":"Cai","year":"2014","journal-title":"Mol. Biol. Cell"},{"issue":"35","key":"10.1016\/j.cellsig.2020.109554_bb0430","doi-asserted-by":"crossref","first-page":"30636","DOI":"10.1074\/jbc.M111.238360","article-title":"The transient receptor potential (TRP) channel TRPC3 TRP domain and AMP-activated protein kinase binding site are required for TRPC3 activation by erythropoietin","volume":"286","author":"Hirschler-Laszkiewicz","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.cellsig.2020.109554_bb0435","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1038\/s41375-019-0468-y","article-title":"The phosphatase UBASH3B\/Sts-1 is a negative regulator of Bcr-Abl kinase activity and leukemogenesis","volume":"33","author":"Mian","year":"2019","journal-title":"Leukemia."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109554_bb0440","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/cr.2016.40","article-title":"Ubiquitin signaling in immune responses","volume":"26","author":"Hu","year":"2016","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109554_bb0445","first-page":"65","article-title":"Protein phosphatases are pest containing proteins","volume":"41","author":"Gomes","year":"1997","journal-title":"Biochem. Mol. Biol. Int."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109554_bb0450","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122149","article-title":"Functional EpoR pathway utilization is not detected in primary tumor cells isolated from human breast, non-small cell lung, colorectal, and ovarian tumor tissues","volume":"10","author":"Patterson","year":"2015","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.cellsig.2020.109554_bb0455","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jim.2009.10.006","article-title":"Identification of a sensitive anti-erythropoietin receptor monoclonal antibody allows detection of low levels of EpoR in cells","volume":"352","author":"Elliott","year":"2010","journal-title":"J. Immunol. Methods"},{"issue":"13","key":"10.1016\/j.cellsig.2020.109554_bb0460","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1158\/0008-5472.CAN-10-3787","article-title":"Erythropoietin induces lymph node lymphangiogenesis and lymph node tumor metastasis","volume":"71","author":"Lee","year":"2011","journal-title":"Cancer Res."},{"issue":"24","key":"10.1016\/j.cellsig.2020.109554_bb0465","doi-asserted-by":"crossref","first-page":"38251","DOI":"10.18632\/oncotarget.16368","article-title":"Erythropoietin drives breast cancer progression by activation of its receptor EPOR","volume":"8","author":"Chan","year":"2017","journal-title":"Oncotarget."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109554_bb0470","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ceb.2004.06.001","article-title":"Cargo recognition during clathrin-mediated endocytosis: a team effort","volume":"16","author":"Sorkin","year":"2004","journal-title":"Curr. Opin. Cell Biol."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109554_bb0475","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1080\/19336918.2017.1394570","article-title":"The pseudokinases SgK269 and SgK223: a novel oncogenic alliance in human cancer","volume":"12","author":"O\u2019Rourke","year":"2018","journal-title":"Cell Adhes. Migr."},{"key":"10.1016\/j.cellsig.2020.109554_bb0480","doi-asserted-by":"crossref","unstructured":"Lecointre C, Simon V, Kerneur C, et al. Dimerization of the Pragmin Pseudo-Kinase Regulates Protein Tyrosine Phosphorylation. Structure. 2018;26(4):545\u2013554 e544.","DOI":"10.1016\/j.str.2018.01.017"},{"issue":"3","key":"10.1016\/j.cellsig.2020.109554_bb0485","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bbrc.2015.08.071","article-title":"Identification of a PEAK1\/ZEB1 signaling axis during TGFbeta\/fibronectin-induced EMT in breast cancer","volume":"465","author":"Agajanian","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109554_bb0490","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-0320-8","article-title":"PEAK1, acting as a tumor promoter in colorectal cancer, is regulated by the EGFR\/KRas signaling axis and miR-181d","volume":"9","author":"Huang","year":"2018","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.cellsig.2020.109554_bb0495","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-0817-1","article-title":"Overexpression of PEAK1 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer through modulating ERK1\/2 and JAK2 signaling","volume":"9","author":"Ding","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2020.109554_bb0500","doi-asserted-by":"crossref","unstructured":"Clark K, Howe JD, Pullar CE, et al. Tensin 2 modulates cell contractility in 3D collagen gels through the RhoGAP DLC1. J Cell Biochem. 2010;109(4):808\u2013817.","DOI":"10.1002\/jcb.22460"},{"key":"10.1016\/j.cellsig.2020.109554_bb0505","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ceb.2016.12.010","article-title":"pHisphorylation: the emergence of histidine phosphorylation as a reversible regulatory modification","volume":"45","author":"Fuhs","year":"2017","journal-title":"Curr. Opin. Cell Biol."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109554_bb0510","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/leu.2015.275","article-title":"UBASH3B\/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO","volume":"30","author":"Goyama","year":"2016","journal-title":"Leukemia."},{"issue":"38","key":"10.1016\/j.cellsig.2020.109554_bb0515","doi-asserted-by":"crossref","first-page":"29338","DOI":"10.1074\/jbc.M003456200","article-title":"CIS3\/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2","volume":"275","author":"Sasaki","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109554_bb0520","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.tips.2017.03.004","article-title":"Targeting tyrosine phosphatases: time to end the stigma","volume":"38","author":"Stanford","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"issue":"13","key":"10.1016\/j.cellsig.2020.109554_bb0525","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1056\/NEJMc051878","article-title":"JAK2 mutations in myeloproliferative disorders","volume":"353","author":"Tefferi","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.cellsig.2020.109554_bb0530","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1038\/leu.2013.119","article-title":"Mutations and prognosis in primary myelofibrosis","volume":"27","author":"Vannucchi","year":"2013","journal-title":"Leukemia."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656820300310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656820300310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:41:47Z","timestamp":1778546507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656820300310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":106,"alternative-id":["S0898656820300310"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2020.109554","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR\/JAK2 Signaling","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2020.109554","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109554"}}